Abstract
Background: Failure of cell division control due to mutations leading to inactivation or over activation of regulatory proteins is the leading cause of cancer development. Several mitogens and growth factors have been found to regulate cancer cell cycle progression. However, all signalling pathways converge to the cell cycle machinery and thus disruption of cell cycle control offers an attractive therapeutic target for the treatment of cancer.
Method: We undertook a comprehensive search of bibliographic databases through PubMed and selected the most relevant and appropriate peer-reviewed research articles.
Results: There has been a breakthrough in identification of the cell cycle regulatory molecules and elucidation of their roles in subtle adjustment of the balance between proliferation and apoptosis of cancer cells. This review will shed light on the current understanding of the regulation of the cell cycle pathway links and the feasibility of targeting cell cycle for fighting metastatic cancer.
Conclusion: There are cross-talks among the diverse neoplastic cell types acting together on cell cycle to ensure survival, growth and metastasis, by inhibiting apoptosis, promoting angiogenesis, and avoiding immune system. Approaches should be undertaken to synergistically block the activation of the interconnected pathways for effective cancer therapy.
Keywords: Cancer, drug targets, cell cycle, metabolic reprogramming, oxidative stress, immunomodulatory microRNAs, extraribosomal functions, CDK, cyclins, genomic instability, check points, p53, therapeutics.
Graphical Abstract
Current Signal Transduction Therapy
Title:Targeting Cell Cycle to Suppress Cancer Aggressiveness
Volume: 12 Issue: 2
Author(s): Jayalaxmi Shetty, Iekhsan Othman, Anuar Zaini and Ezharul Hoque Chowdhury*
Affiliation:
- Jeffrey Cheah School of Medicine and Health Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway,Malaysia
Keywords: Cancer, drug targets, cell cycle, metabolic reprogramming, oxidative stress, immunomodulatory microRNAs, extraribosomal functions, CDK, cyclins, genomic instability, check points, p53, therapeutics.
Abstract: Background: Failure of cell division control due to mutations leading to inactivation or over activation of regulatory proteins is the leading cause of cancer development. Several mitogens and growth factors have been found to regulate cancer cell cycle progression. However, all signalling pathways converge to the cell cycle machinery and thus disruption of cell cycle control offers an attractive therapeutic target for the treatment of cancer.
Method: We undertook a comprehensive search of bibliographic databases through PubMed and selected the most relevant and appropriate peer-reviewed research articles.
Results: There has been a breakthrough in identification of the cell cycle regulatory molecules and elucidation of their roles in subtle adjustment of the balance between proliferation and apoptosis of cancer cells. This review will shed light on the current understanding of the regulation of the cell cycle pathway links and the feasibility of targeting cell cycle for fighting metastatic cancer.
Conclusion: There are cross-talks among the diverse neoplastic cell types acting together on cell cycle to ensure survival, growth and metastasis, by inhibiting apoptosis, promoting angiogenesis, and avoiding immune system. Approaches should be undertaken to synergistically block the activation of the interconnected pathways for effective cancer therapy.
Export Options
About this article
Cite this article as:
Shetty Jayalaxmi , Othman Iekhsan, Zaini Anuar and Chowdhury Hoque Ezharul *, Targeting Cell Cycle to Suppress Cancer Aggressiveness, Current Signal Transduction Therapy 2017; 12 (2) . https://dx.doi.org/10.2174/1574362412666170330145949
DOI https://dx.doi.org/10.2174/1574362412666170330145949 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Databases and their Potential in Pharmacogenomics
Current Pharmaceutical Design FOXM1 and its Oncogenic Signaling in Gastric Cancer
Recent Patents on Anti-Cancer Drug Discovery Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs
Current Drug Delivery [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells
Anti-Cancer Agents in Medicinal Chemistry Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future
Current Immunology Reviews (Discontinued) MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Synthetic Lethality-Based Therapeutics: Perspectives for Applications in Colorectal Cancer
Current Cancer Drug Targets Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Current Cancer Drug Targets The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies
Current Cancer Drug Targets Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance
Current Medicinal Chemistry TEM8 Targeted Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry New Insights into the Roles of XPA and RPA in DNA Repair and Damage Responses
Current Chemical Biology Evaluation of Salivary Antioxidants and Oxidative Stress Markers in Male Smokers
Combinatorial Chemistry & High Throughput Screening Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Cytochrome P450 Structure, Function and Clinical Significance: A Review
Current Drug Targets The Vitamin D Saga: Breaking Dawn
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial (Thematic Issue: Targeting Cell Death and Proliferation Receptors in Cancer)
Current Pharmaceutical Design A Novel 99mTc-labeled Diphosphonic Acid as Potential Bone Seeking Agent: Synthesis and Biological Evaluation
Current Radiopharmaceuticals Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design